General Information of the Compound
| Compound ID |
CP0411791
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[8-[(5-cyclopropyl-2-methoxypyridin-3-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H27N3O5
|
||||||||||||||||||
| Molecular Weight |
437.496
|
||||||||||||||||||
| Canonical SMILES |
COc1ncc(cc1CN1CCC2(CN(C(=O)O2)c2ccc(cc2)C(O)=O)CC1)C1CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H27N3O5/c1-31-21-19(12-18(13-25-21)16-2-3-16)14-26-10-8-24(9-11-26)15-27(23(30)32-24)20-6-4-17(5-7-20)22(28)29/h4-7,12-13,16H,2-3,8-11,14-15H2,1H3,(H,28,29)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JVPIRQTTWZBUQB-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01196, Somatostatin receptor type 5
Protein ID: PT06443, Somatostatin receptor type 5